Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

NCT00845507 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Weight Gain

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

University of Cincinnati

Collaborators

[object Object]